Steric stabilization of bioactive nanoparticles using elastin-like polypeptides

Adv Drug Deliv Rev. 2024 Mar:206:115189. doi: 10.1016/j.addr.2024.115189. Epub 2024 Jan 26.

Abstract

Elastin-like polypeptides (ELP) are versatile, thermo-responsive polymers that can be conjugated to virtually any therapeutic cargo. Derived from short amino-acid sequences and abundant in humans, certain ELPs display low immunogenicity. Substrates for endogenous proteases, ELPs are biodegradable and thus, are candidate biomaterials. Peptides and proteins can be directly coupled with ELPs through genetic engineering, while other polymers and small molecules can be appended through covalent bioconjugation or non-covalent complexation. ELPs that phase separate at physiological temperatures can form the core of nano assemblies; however, ELPs that remain soluble can sterically stabilize the corona of a variety of nanoparticles. Nanoparticles with ELPs at their corona promote colloids with favorable pharmacokinetic (PK) properties that enables therapeutic efficacy with intermittent administration. This review highlights a comprehensive spectrum of ELP fusions shown to stabilize the solubility, and sometimes bioactivity, of their cargo - with a focus on biophysical properties that underlie their therapeutic effects.

Keywords: Biodegradable; Biomaterial; Colloid; Drug delivery; Dynamic light scattering; ELP; Micelle; Nanomedicine; Protein polymers; Transmission electron microscopy.

Publication types

  • Review

MeSH terms

  • Amino Acid Sequence
  • Elastin / chemistry
  • Elastin-Like Polypeptides*
  • Humans
  • Nanoparticles* / chemistry
  • Peptides / chemistry

Substances

  • Elastin-Like Polypeptides
  • Elastin
  • Peptides